Penserra Capital Management LLC Celularity Inc Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.81 - $12.91 $8,505 - $39,078
-3,027 Reduced 64.57%
1,661 $5,000
Q1 2022

May 13, 2022
BUY
$3.81 - $9.79 $514 - $1,321
135 Added 2.97%
4,688 $40,000
Q4 2021

Feb 15, 2022
SELL
$4.64 - $7.46 $37,180 - $59,776
-8,013 Reduced 63.77%
4,553 $23,000
Q3 2021

Nov 15, 2021
BUY
$6.05 - $12.15 $76,024 - $152,676
12,566 New
12,566 $88,000

Others Institutions Holding CELU

# of Institutions
3
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About Celularity Inc

CELU Quotes by TradingView
  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email